Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer (COPE study)
Abstract Germline TP53 pathogenic variants are rare but associated with a high risk of cancer; they are often identified in the context of clinically diagnosed Li–Fraumeni syndrome predisposing to a range of young onset cancers including sarcomas and breast cancer. The study aim was to conduct a det...
Main Authors: | Kate Packwood, Guy Martland, Matthew Sommerlad, Emily Shaw, Karwan Moutasim, Gareth Thomas, Adrian C Bateman, Louise Jones, Linda Haywood, D Gareth Evans, Jillian M Birch, Ohud A Alsalmi, Alex Henderson, Nicola Poplawski, Diana M Eccles |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-07-01
|
Series: | The Journal of Pathology: Clinical Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/cjp2.133 |
Similar Items
-
Intronic <it>TP53 </it>Germline Sequence Variants Modify the Risk in German Breast/Ovarian Cancer Families
by: Liu Xuan, et al.
Published: (2004-07-01) -
New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman
by: P. A. Gervas, et al.
Published: (2022-01-01) -
Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese
by: Bing Wei, et al.
Published: (2023-12-01) -
Assessing germline TP53 mutations in cancer patients: insights into Li-Fraumeni syndrome and genetic testing guidelines
by: Anastasiia Danishevich, et al.
Published: (2025-02-01) -
Germline mutations of TP53 gene can be a key factor in prostate cancer genesis
by: Kawtar Aboulalaa, et al.
Published: (2024-10-01)